Carole Bradley-Kennedy

Statistics

Publications

Citations

650

H-Index

Active since

2007

Affiliations

Boehringer Ingelheim (Canada)(Current)

University of British Columbia

Vancouver Coastal Health

Vancouver Coastal Health Research Institute

Carole Bradley-Kennedy is an author at Boehringer Ingelheim (Canada) specializing in pharmacoeconomics, clinical pharmacology, and obstructive lung disease.

Publications per year

2007–2013

Publications

The cost of moderate and severe COPD exacerbations to the Canadian healthcare system

Nicole Mittmann, Lisa Kuramoto, Soo Jin Seung et al. · Respiratory Medicine · 2007 · 221 citations · Full text

Medicine, Health Systems, Pharmacoeconomics +14

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective

Stuart Connolly, Siyang Peng, John E. Linnehan et al. · Thrombosis and Haemostasis · 2011 · 204 citations

Medicine, Pharmacoeconomics, Pharmacotherapy +17

Treatment Persistence and Compliance with Medications for Chronic Obstructive Pulmonary Disease

Joyce A. Cramer, Carole Bradley-Kennedy, Alissa Scalera · Canadian Respiratory Journal · 2007 · 104 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada

Michael Sharma, Carole Bradley-Kennedy, Andreas Clemens et al. · Thrombosis and Haemostasis · 2012 · 56 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Resource Use Study in COPD (RUSIC): A prospective Study to Quantify the Effects of COPD Exacerbations on Health Care Resource Use Among COPD Patients

J. Mark FitzGerald, Jennifer Haddon, Carole Bradley-Kennedy et al. · Canadian Respiratory Journal · 2007 · 50 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +11

1–5 of 6